Department of Gastrointestinal Surgery, The First Affiliated Hospital of Medical College, Shihezi University, Shihezi, China.
Shihezi University School of Medicine, Shihezi, China.
Oncology. 2020;98(3):138-145. doi: 10.1159/000504174. Epub 2019 Nov 13.
RNA polymerase I subunit D (POLR1D) is involved in the synthesis of ribosomal RNA precursors and small RNAs, but its mechanism in the development and progression of colorectal cancer (CRC) remains ambiguous. Thus, this research aimed to investigate POLR1D's expression and significance in human CRC patients and evaluate its association with clinicopathological characteristics.
Matched fresh-frozen cancerous and non-cancerous tissues were collected from 100 patients diagnosed with CRC. Immunohistochemical, Western blot, and quantitative real-time polymerase chain reaction analyses were adopted to validate the correlation between POLR1D expression and clinicopathological parameters in CRC tissues and adjacent normal tissues (ANTs).
POLR1D expression in CRC tissues was significantly higher than in the ANTs. χ2 test and Spearman's correlative analysis showed that a high POLR1D expression is significantly associated with clinical stage, Dukes stage, tumor differentiation, depth of invasion, and metastasis (p < 0.05). It is not correlated with gender, age, and tumor location and size (p > 0.05). Kaplan-Meier survival curves show that the overall survival (OS) time for the low expression group is remarkably longer than for the high expression group (p < 0.0015). Univariate and multivariate analyses indicate that a high POLR1D expression is an independent prognostic factor for poor OS (p = 0.000).
The findings of this study strongly indicate that POLR1D plays a pivotal role in the occurrence and progression of CRC. It might be an independent adverse prognostic factor for CRC patients and could serve as a potential therapeutic target for clinical diagnosis in CRC and anticancer drug development.
RNA 聚合酶 I 亚单位 D(POLR1D)参与核糖体 RNA 前体和小 RNA 的合成,但它在结直肠癌(CRC)发生和发展中的作用仍不清楚。因此,本研究旨在探讨 POLR1D 在人 CRC 患者中的表达及其意义,并评估其与临床病理特征的关系。
收集了 100 例 CRC 患者的配对新鲜冷冻癌组织和非癌组织。采用免疫组织化学、Western blot 和定量实时聚合酶链反应分析来验证 POLR1D 在 CRC 组织和相邻正常组织(ANTs)中的表达与临床病理参数之间的相关性。
CRC 组织中 POLR1D 的表达明显高于 ANTs。χ2 检验和 Spearman 相关分析表明,高 POLR1D 表达与临床分期、Dukes 分期、肿瘤分化、浸润深度和转移显著相关(p<0.05)。与性别、年龄、肿瘤位置和大小无关(p>0.05)。Kaplan-Meier 生存曲线显示,低表达组的总生存期(OS)明显长于高表达组(p<0.0015)。单因素和多因素分析表明,高 POLR1D 表达是 OS 不良的独立预后因素(p=0.000)。
本研究结果表明,POLR1D 在 CRC 的发生和发展中起着关键作用。它可能是 CRC 患者不良预后的独立预测因子,并可能成为 CRC 临床诊断和抗癌药物开发的潜在治疗靶点。